The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy.
Though complement (C) deposition within the transplant is associated with allograft rejection, the pathways employed have not been established. In addition, evidence suggests that C-mediated cytolysis may be necessary for the tolerance-inducing activities of mAb therapies. Hence, we assessed the role of the classical C pathway in acute allograft rejection and its requirement for experimental mAb therapies. C1q-deficient (C1q-/-) recipients rejected allografts at a faster rate than wild-type (WT) recipients. This rejection was associated with exacerbated graft pathology but not with enhanced T-cell responses in C1q-/- recipients. However, the humoral response to donor alloantigens was accelerated in C1q-/- mice, as an early IgG response and IgG deposition within the graft were observed. Furthermore, deposition of C3d, but not C4d was observed in grafts isolated from C1q-/- recipients. To assess the role of the classical C pathway in inductive mAb therapies, C1q-/- recipients were treated with anti-CD4 or anti-CD40L mAb. The protective effects of anti-CD4 mAb were reduced in C1q-/- recipients, however, this effect did not correlate with ineffective depletion of CD4+ cells. In contrast, the protective effects of anti-CD40L mAb were less compromised in C1q-/- recipients. Hence, this study reveals unanticipated roles for C1q in the rejection process.
Csencsits
K
K
Section of General Surgery, Department of Surgery, University of Michigan School of Medicine, Ann Arbor, MI, USA. keri.c.smith@uth.tmc.edu
Burrell
B E
BE
Lu
G
G
Eichwald
E J
EJ
Stahl
G L
GL
Bishop
D K
DK
D000818:Animals; D000911:Antibodies, Monoclonal; D015922:Complement C1q / Q000378:metabolism*; D003171:Complement Pathway, Classical; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D007074:Immunoglobulin G / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D012720:Severity of Illness Index; D023001:Transplantation Tolerance / Q000502:physiology*
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D015922:Complement C1q